Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lycke

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Idrugs : the Investigational Drugs Journal|September 15, 2005
Novel enabling technologies for vaccine development. 26-27 January 1999, Royal Society, London, UKN Lycke
Chemical Immunology|October 8, 1998
T cell and cytokine regulation of the IgA responseN Lycke
Advances in Experimental Medicine and Biology|January 1, 1995
Analysis of the second messenger systems involved in the synergistic effect of cholera toxin and interleukin-4 on B cell isotype-switchingN Lycke
Research in Immunology|May 20, 1998
The mechanism of cholera toxin adjuvanticityN Lycke
Scandinavian Journal of Immunology|October 1, 1986
A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cellsN Lycke
Current Opinion in Molecular Therapeutics|March 16, 2001
The B-cell targeted CTA1-DD vaccine adjuvant is highly effective at enhancing antibody as well as CTL responsesN Lycke
Vaccine|November 15, 2003
The CTA1-DD vaccine adjuvant binds to human B cells and potentiates their T cell stimulating abilityA Eriksson, N Lycke
Immunology|November 1, 1995
Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunizationM Vajdy, N Lycke
Advances in Experimental Medicine and Biology|January 1, 1995
Presence of antigen-specific long-term memory cells in systemic lymphoid tissues as well as locally in the gut lamina propria following oral immunization with cholera toxin adjuvantM Vajdy, N Lycke
Advances in Experimental Medicine and Biology|January 1, 1995
Cholera toxin increases T lymphocyte responses to unrelated antigensE Hornquist, N Lycke
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Idrugs : the Investigational Drugs Journal|September 15, 2005
Novel enabling technologies for vaccine development. 26-27 January 1999, Royal Society, London, UKN Lycke
Chemical Immunology|October 8, 1998
T cell and cytokine regulation of the IgA responseN Lycke
Advances in Experimental Medicine and Biology|January 1, 1995
Analysis of the second messenger systems involved in the synergistic effect of cholera toxin and interleukin-4 on B cell isotype-switchingN Lycke
Research in Immunology|May 20, 1998
The mechanism of cholera toxin adjuvanticityN Lycke
Scandinavian Journal of Immunology|October 1, 1986
A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cellsN Lycke
Current Opinion in Molecular Therapeutics|March 16, 2001
The B-cell targeted CTA1-DD vaccine adjuvant is highly effective at enhancing antibody as well as CTL responsesN Lycke
Vaccine|November 15, 2003
The CTA1-DD vaccine adjuvant binds to human B cells and potentiates their T cell stimulating abilityA Eriksson, N Lycke
Immunology|November 1, 1995
Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunizationM Vajdy, N Lycke
Advances in Experimental Medicine and Biology|January 1, 1995
Presence of antigen-specific long-term memory cells in systemic lymphoid tissues as well as locally in the gut lamina propria following oral immunization with cholera toxin adjuvantM Vajdy, N Lycke
Advances in Experimental Medicine and Biology|January 1, 1995
Cholera toxin increases T lymphocyte responses to unrelated antigensE Hornquist, N Lycke
Pageof 9